Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 11/02/22 → 31/12/24 |
Keywords
- Medical oncology
- Ovarian cancer
- Clinical trial
Clinical Trial Phase
- Phase II
PICCOLO: A Phase 2, single arm study of Mirvetuximab Soravtansine in recurrent platinum-sensitive, high-grade epithelial ovarian, primary peritoneal, or fallopian tube cancers with high folate receptor-alpha expression.
- Richardson, Gary (Primary Chief Investigator (PCI))
- Spence, Anne (Project Manager)
Project: Research